Public Companies
Evan Levine, CEO of PsyBio Therapeutics, Sits in the Investor Hotseat on October 13th
PsyBio Therapeutics ($PSYB) CEO, Evan Levine, joins the Investor Hotseat to field hot questions from host, Dustin Robinson of Iter Investments. Psybio…

PsyBio Therapeutics ($PSYB) CEO, Evan Levine, joins the Investor Hotseat to field hot questions from host, Dustin Robinson of Iter Investments.
Psybio has developed a portfolio of bio-medical chemistry development psycho-targeted compounds for the potential treatment for mental and neurological health.
Evan himself is a leader encompassing more than two decades of in-depth expertise in strategic ventures, executive supervision, asset management, and institutional investment businesses. He has served on the public and private boards of over a dozen companies in roles that include Chairman of the Board, Executive Chairman, Vice Chairman, Chief Executive Officer, Audit Committee Chairman, Nominating / Governance / Compensation Committee Member, and Trustee.
Will Evan be able to handle the heat in the hotseat?
As always, this will be a live event. You’ll be able to stream it from the Psychedelic Invest website, YouTube, LinkedIn, Facebook, Twitch, and Twitter. If you miss it, though, don’t worry. It will be recorded and available across those channels after the event.
If you’d like to attend the live event, you can set a reminder on Youtube or LinkedIn. Or, you can come back to the Hotseat livestream page at the time of the event.
To RSVP to ensure your spot, please fill out the form below.
A Transcription Will Be Available Following the Event

-
Psilocybin19 hours ago
Analysts Probe Compass Pathways About Johnson & Johnson’s Spravato
-
Markets & Investing20 hours ago
BREAKING: Kentucky To Invest in Ibogaine Treatment for Addiction
-
Other19 hours ago
Tots ingested drugs, parents arrested in separate NYC cases: cops
-
Private Companies18 hours ago
Researchers describe the life cycle of four species of the world’s most venomous caterpillars, genus Lonomia Walker, and discover new parasitoids and host plants
-
Psilocybin23 hours ago
Compass Pathways Co-founder Steps Down
-
Psilocybin3 hours ago
Compass Pathways’ COMP360 Produces 50% Long-Term Depression Remission in Cancer Patients